JPRN-UMIN000003260招募中2 期
Phase II study of second line chemotherapy with carboplatin and paclitaxel for metastatic melanoma - Phase II study of second line chemotherapy with carboplatin and paclitaxel for metastatic melanoma
Division of Skin Oncology, Comprehensive cancer center, Saitama medical university International medical center0 个研究点目标入组 40 人开始时间: 2010年2月26日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who have brain metastases which are not controlled by surgery or radiotherapy 2. Patients without myelosuppresion-Neutrophilic leukocyte<1,500/mm3, PLT<100,000/mm3 3. Patients with severe disorders in heart (NYHA Grade 2 or more), lung, liver, kidney or brain. 4. Patients who are pregnant or nursing 5. Patients who are judged inappropriate to be enrolled in this study by the doctor in charge.
研究者
相似试验
已完成
不适用
Phase II study of second-line chemotherapy using CPT-11 plus CDDP in patients with advanced/recurrent gastric cancer (OGSG 0504)Advanced/Recurrent gastric cancer which has no response to S-1JPRN-UMIN000000693Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)35
招募中
2 期
Phase II Study of neoadjuvant chemotherapy with carboplatin,pemetrexed and bevacizumab in patients with non-squemous non-small-cell lung canceron-squamous,non-small-cell lung cancerJPRN-UMIN000006759niversity of Tsukuba, Faculty of Medicine, Department of Thoracic Surgery30
已完成
不适用
Phase II study of second-line chemotherapy using modified FOLFOX6 in patients with advanced/ recurrent colorectal cancer (OGSG 0505)Patients with unresectable or metastatic colon cancer registant to fluorouracil treatmentJPRN-UMIN000000841OGSG50
招募中
2 期
Phase II study of neo-adjuvant chemotherapy with combination therapy of gemcitabine and S-1 in patients with resectable pancreatic cancerresectable pancreatic cancerJPRN-UMIN000005912Tokai university, school of medicine50
尚未招募
1 期
Phase 1/2 study of combination chemotherapy with Carboplatin, nab-Paclitaxel, and Bevacizumab for advanced non-squamous non-small cell lung canceron-squamous Non-small-cell Lung CancerJPRN-UMIN000016735Hiroshima Asa City Hospital35